Futura Medical plc (AIM:FUM)

Market Cap	3.20M -89.2%
Revenue (ttm)	1.70M -87.8%
Net Income	-9.07M
EPS	-0.03
Shares Out	581.33M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	354,713
Open	0.6800
Previous Close	0.5500
Day's Range	0.5520 - 0.6800
52-Week Range	0.5000 - 15.0000
Beta	0.02
Analysts	Strong Buy
Price Target	30.00 (+4,480.85%)
Earnings Date	Jun 17, 2026

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 14
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: FUM

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 16, 2026

Data Sources Report a data error